N-Power Medicine

What N-Power Medicine does

N-Power Medicine is a private, venture-backed clinical trial technology company founded in 2021 and headquartered in Redwood City, California. The company builds an integrated platform that combines clinical trial operations with point-of-care patient care workflows inside community oncology practices. Its core products are a Point-of-Care Platform — which embeds on-site clinical research specialists and workflow tooling directly inside clinics — and a Patient Registry that aggregates genomic and clinical data for biomarker-informed trial matching. A separate Integrated Clinical Trial Platform layer connects these capabilities to biopharmaceutical sponsors for drug development collaborations.

Underneath the product surface, N-Power operates a Medical Intelligence Layer that uses multi-LLM ensembles to process patient records and clinical documentation, automated casefinding to flag time-sensitive treatment windows across a patient's cancer journey, and knowledge retrieval to match registry patients to eligible trials. The company expanded its data and analytics footprint through the January 2025 acquisition of Syapse, broadening its real-world oncology data capabilities.

N-Power generates revenue through subscription/recurring platform services delivered to community oncology practices and through biopharma collaborations that leverage the integrated platform for trial execution and patient access. It has raised $85 million in total funding, including a $72 million Series B in July 2024 led by Merck Global Health Innovation Fund, and serves customers across two primary verticals — community oncology practices (e.g., Pacific Cancer Care as a pilot site) and biopharmaceutical companies. Pricing is not publicly disclosed.

Name

N-Power Medicine

Legal name

N-Power Medicine

Website

https://npowermedicine.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

101–250 employees

Short description

N-Power Medicine is a private oncology clinical trial technology company that integrates point-of-care trial workflows and genomic patient registries into community oncology practices, serving biopharmaceutical sponsors and cancer patients, with AI-driven documentation and casefinding capabilities.

Ownership category

akta.pro rank

Product category

Clinical Trial Technology

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Decentralized/Hybrid Trial Enablement (DCT) Platforms (HLACAOAL)

akta.pro secondary industries

Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)

Keywords

• Clinical trial platform
• Oncology research
• Patient registry
• Biomarker testing
• Precision oncology

Headquarters

HQ city

Redwood City

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Platform Services to Oncology Clinics: Providing integrated clinical trial technology and on-site clinical research specialists to community oncology practices
2. Biopharmaceutical Collaborations: Collaborations with biopharmaceutical companies leveraging the integrated platform for clinical trials and patient data

Go-to-market motion2 records

Distribution channels1 record

Marketing channels2 records

Core offering

N-Power Medicine operates an integrated clinical trial platform that embeds on-site clinical research specialists and point-of-care technology within community oncology practices to identify eligible patients, collect genomic data, and enroll them in biomarker-informed clinical trials. The company's offerings include a Point-of-Care Platform, a Patient Registry for genomic data, and an overarching Integrated Clinical Trial Platform connecting research workflows with patient care.

Product overview

N-Power Medicine offers an integrated clinical trial platform designed for oncology clinics and biopharmaceutical collaborations. The core offering consists of the Point-of-Care Platform, which provides on-site clinical research specialists and workflow integration within community oncology practices, supported by a Patient Registry for genomic data collection and patient matching. The company also operates an Integrated Clinical Trial Platform that connects clinical research with patient care workflows, enabling the expansion of oncology clinic networks and facilitating collaborations with biopharmaceutical companies for drug development.

Differentiator

Problem solved

Functional benefit

Products and services

• Integrated Clinical Trial Platform Unified software platform that combines clinical trial management with patient care workflows, enabling on-site clinical research specialists to identify eligible patients, collect genomic data, and enroll cancer patients in biomarker-informed clinical trials within community oncology practices. The platform supports expansion of the oncology clinic network and biopharmaceutical collaborations.

Quantifiable outcome

• Improved genetic testing rates through integrated digital tools and workflow automation

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature3 records

Partnerships

Two partnerships are on record, tiered core and pilot.

• My Gene CounselcoreStrategic or Co-development Partner · 9 April 2026Launched precision medicine pilot at Pacific Cancer Care integrating My Gene Counsel's digital genetic counseling platform with N-Power Medicine's point-of-care technology. The collaboration aims to expand patient access to guideline-recommended hereditary cancer risk assessment and testing, with plans to expand to additional oncology practices nationwide.
• Pacific Cancer CarepilotStrategic or Co-development Partner · 9 April 2026Site of precision medicine pilot program in Monterey, California focused on improving genetic testing rates and biomarker-informed clinical trial enrollment for cancer patients.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Flatiron Health: Flatiron Health operates an oncology-specific EHR and real-world data platform serving community oncology practices and biopharmaceutical companies for clinical trial and evidence generation. It is the most directly comparable competitor to N-Power Medicine, with overlapping customer base and use cases around oncology data and trial enablement.
• Syapse: Syapse is a real-world evidence company focused on oncology, connecting health systems, providers, and biopharmaceutical companies through a shared data platform. Now part of N-Power Medicine following the January 2025 acquisition, it is the most direct peer in the oncology RWD/RWE category.
• Tempus: Tempus is an AI-powered precision medicine company combining genomic sequencing, data libraries, and clinical trial connectivity for oncology. It is comparable to N-Power in its genomic data assets, AI capability, and biopharma-facing clinical trial services.
• Science 37: Science 37 is a decentralized clinical trial enablement platform that recruits, retains, and manages patients remotely across therapeutic areas including oncology. It is directly comparable to N-Power's DCT enablement category, though it focuses on fully remote rather than community-embedded models.
• Circuit Clinical: Circuit Clinical is a clinical trial site network focused on community-based physician practices, integrating research into routine care workflows. Its community-embedded trial model is closely comparable to N-Power's point-of-care platform approach.

Broad incumbents

• Medidata (Dassault Systèmes): Medidata provides the industry-leading eCOA, EDC, and decentralized trial platform (Rave) used by the majority of large biopharma sponsors. It is a broad incumbent that overlaps with N-Power in clinical trial technology infrastructure and biopharma customer base.
• IQVIA: IQVIA is the largest global CRO and clinical trial technology provider, offering site networks, real-world data, and DCT capabilities. It is a broad incumbent competing with N-Power across biopharma R&D services and clinical trial enablement.

Emerging players

• Paradigm Health: Paradigm Health builds technology-enabled clinical trial infrastructure aimed at broadening access and improving trial execution in oncology and other serious diseases. It is an emerging player with partial overlap in DCT enablement and biopharma trial services.
• Castor: Castor is a clinical trial technology platform offering EDC, ePRO, and decentralized trial capabilities with strong interoperability. It is an emerging player in DCT enablement that competes for biopharma and academic trial technology spend alongside N-Power.
• Deep 6 AI: Deep 6 AI applies AI to structured and unstructured EHR data to accelerate clinical trial patient recruitment across health systems and community sites. It is comparable to N-Power's AI-powered casefinding and registry-driven trial enrollment approach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/n-power-medicine-inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about N-Power Medicine